TABLE 2.
Patients' characteristics by muscle status
| Without muscle wasting (n = 221) | With muscle wasting (n = 47) | P‐value | |
|---|---|---|---|
| Age (years) | 66.12 ± 11.04 | 71.94 ± 8.60 | 0.001 |
| Sex (% female) | 55 (24.9%) | 2 (4.3%) | 0.001 |
| Iron deficiency (%) | 103 (46.8%) | 34 (72.3%) | 0.002 |
| Anaemia (%) | 59 (26.7%) | 22 (46.8%) | 0.009 |
| NYHA class | 2.29 ± 0.60 | 2.47 ± 0.72 | 0.1 |
| GFR (CKD‐EPI, mL/min) | 59.80 ± 14.93 | 59.05 ± 14.53 | 0.8 |
| NT‐proBNP (ng/L) | 1272 ± 2469 | 2459 ± 3467 | <0.001 |
| Albumin (g/L) | 37.26 ± 3.62 | 36.09 ± 4.27 | 0.055 |
| Transferrin (mg/dL) | 267.81 ± 45.64 | 280.23 ± 63.29 | 0.207 |
CKD‐EPI, Chronic Kidney Disease Epidemiology Collaboration; GFR, glomerular filtration rate; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide; NYHA, New York Heart Association.